
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He, Hua Jiang, Yun Chen, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 614
Hongbin He, Hua Jiang, Yun Chen, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 614
Showing 26-50 of 614 citing articles:
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
Qiang Ma
Pharmacological Reviews (2023) Vol. 75, Iss. 3, pp. 487-520
Open Access | Times Cited: 93
Qiang Ma
Pharmacological Reviews (2023) Vol. 75, Iss. 3, pp. 487-520
Open Access | Times Cited: 93
Pyroptosis and pyroptosis-inducing cancer drugs
Fan Yang, Sahana Bettadapura, Mark S. Smeltzer, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2462-2473
Open Access | Times Cited: 88
Fan Yang, Sahana Bettadapura, Mark S. Smeltzer, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2462-2473
Open Access | Times Cited: 88
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 88
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 88
DAMPs and DAMP-sensing receptors in inflammation and diseases
Ming Ma, Wei Jiang, Rongbin Zhou
Immunity (2024) Vol. 57, Iss. 4, pp. 752-771
Open Access | Times Cited: 79
Ming Ma, Wei Jiang, Rongbin Zhou
Immunity (2024) Vol. 57, Iss. 4, pp. 752-771
Open Access | Times Cited: 79
The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases
Xuan Shi, Huanping Zhou, Juan Wei, et al.
Redox Biology (2022) Vol. 58, pp. 102553-102553
Open Access | Times Cited: 72
Xuan Shi, Huanping Zhou, Juan Wei, et al.
Redox Biology (2022) Vol. 58, pp. 102553-102553
Open Access | Times Cited: 72
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 59
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 59
Natural Extracts for Antibacterial Applications
Cuihong Chen, Lin Chen, Congyang Mao, et al.
Small (2023) Vol. 20, Iss. 9
Open Access | Times Cited: 50
Cuihong Chen, Lin Chen, Congyang Mao, et al.
Small (2023) Vol. 20, Iss. 9
Open Access | Times Cited: 50
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 48
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 48
Involvement of inflammasomes in tumor microenvironment and tumor therapies
Ziqi Zhang, Xue Li, Yang Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 47
Ziqi Zhang, Xue Li, Yang Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 47
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 31
NLRP3 inflammasome signalling in Alzheimer's disease
Róisín M. McManus, Eicke Latz
Neuropharmacology (2024) Vol. 252, pp. 109941-109941
Open Access | Times Cited: 30
Róisín M. McManus, Eicke Latz
Neuropharmacology (2024) Vol. 252, pp. 109941-109941
Open Access | Times Cited: 30
Plant-Derived Terpenoids: A Plethora of Bioactive Compounds with Several Health Functions and Industrial Applications—A Comprehensive Overview
José S. Câmara, Rosa Perestrelo, Rui Ferreira, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3861-3861
Open Access | Times Cited: 30
José S. Câmara, Rosa Perestrelo, Rui Ferreira, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3861-3861
Open Access | Times Cited: 30
NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 29
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 29
Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation
Juan Bu, Yeledan Mahan, Shengnan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Juan Bu, Yeledan Mahan, Shengnan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure
Tobias Eckle, Júlia Bertazzo, Tarak Nath Khatua, et al.
Circulation Research (2024) Vol. 134, Iss. 6, pp. 675-694
Closed Access | Times Cited: 17
Tobias Eckle, Júlia Bertazzo, Tarak Nath Khatua, et al.
Circulation Research (2024) Vol. 134, Iss. 6, pp. 675-694
Closed Access | Times Cited: 17
Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 2
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 2
Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment
Jing-wen Guo, Guo‐Qiang Lin, Xinyi Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 2
Jing-wen Guo, Guo‐Qiang Lin, Xinyi Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 2
Ginsenoside Rg2, a principal effective ingredient of Panax ginseng, attenuates DSS-induced ulcerative colitis through NF-κB/NLRP3 pathway
Ji Zhang, Jing Xie, Zhiqiang Niu, et al.
Journal of Ginseng Research (2025)
Open Access | Times Cited: 2
Ji Zhang, Jing Xie, Zhiqiang Niu, et al.
Journal of Ginseng Research (2025)
Open Access | Times Cited: 2
Divergent synthesis of complex diterpenes through a hybrid oxidative approach
Xiao Zhang, Emma King‐Smith, Liao‐Bin Dong, et al.
Science (2020) Vol. 369, Iss. 6505, pp. 799-806
Open Access | Times Cited: 136
Xiao Zhang, Emma King‐Smith, Liao‐Bin Dong, et al.
Science (2020) Vol. 369, Iss. 6505, pp. 799-806
Open Access | Times Cited: 136
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
Iva Hafner‐Bratkovič, Petra Sušjan, Duško Lainšček, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 120
Iva Hafner‐Bratkovič, Petra Sušjan, Duško Lainšček, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 120
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
Adam G. Schwaid, Kerrie B. Spencer
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 101-122
Closed Access | Times Cited: 105
Adam G. Schwaid, Kerrie B. Spencer
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 101-122
Closed Access | Times Cited: 105
Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
Guang Xu, Shubin Fu, Xiaoyan Zhan, et al.
JCI Insight (2020) Vol. 6, Iss. 2
Open Access | Times Cited: 103
Guang Xu, Shubin Fu, Xiaoyan Zhan, et al.
JCI Insight (2020) Vol. 6, Iss. 2
Open Access | Times Cited: 103
The inflammasome in host response to biomaterials: Bridging inflammation and tissue regeneration
Daniela P. Vasconcelos, Artur P. Águas, Mário A. Barbosa, et al.
Acta Biomaterialia (2018) Vol. 83, pp. 1-12
Closed Access | Times Cited: 101
Daniela P. Vasconcelos, Artur P. Águas, Mário A. Barbosa, et al.
Acta Biomaterialia (2018) Vol. 83, pp. 1-12
Closed Access | Times Cited: 101